Your browser doesn't support javascript.
loading
Retrospective cohort study on linezolid in empirical treatment of methicillin-resistant Staphylococcus pneumonia / 中华临床感染病杂志
Article de Zh | WPRIM | ID: wpr-416710
Bibliothèque responsable: WPRO
ABSTRACT
Objective To evaluate the efficacy and safety of linezolid in empirical treatment of methicillin-resistant Staphylococcus (MRS) pneumonia. Methods One hundred and thirty-five hospitalized patients with MSR pneumonia receiving linezolid from April 2009 to October 2010 were enrolled in this retrospective cohort study, and all subjects were assigned to two groups: 75 cases with empirical treatment (linezolid 0. 6 g by infusion q12h at admission) , and 60 cases with objective treatment (linezolid after the sputum culture). The severity score, clinical effect and adverse effect were observed, and the therapeutic effects in patients with high risk factors were especially evaluated. SPSS13.0 software was used for statistical analysis. Results The scores were decreased significantly after finishing therapeutic causes for 3 and 7 days in both groups (tempirical =12.29 and 16.53, tobjective =9.36 and 11.49, P 0.05 ). In the patients with high risk factors, the effective rates of two groups were 86. 8% (33/38) and 63. 6% (14/22) , and the difference was significant (x2 =4.42, P 0. 05). Conclusion Linezolid can be used as empirical treatment for MRS pneumonia with rapid symptoms relieve and high efficacy, especially for patients with high risk.
Mots clés
Texte intégral: 1 Indice: WPRIM Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies langue: Zh Texte intégral: Chinese Journal of Clinical Infectious Diseases Année: 2011 Type: Article
Texte intégral: 1 Indice: WPRIM Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies langue: Zh Texte intégral: Chinese Journal of Clinical Infectious Diseases Année: 2011 Type: Article